GILEAD SCIENCE INC has a total of 21 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Canada, Brazil and Chile. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are GILEAD SCIENCES, BASILEA PHARMACEUTICA AG and FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA PERMSKAYA G.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 7 | |
#2 | Brazil | 2 | |
#3 | Chile | 2 | |
#4 | Iceland | 2 | |
#5 | United States | 2 | |
#6 | Uruguay | 2 | |
#7 | African Regional Industrial Property Organization | 1 | |
#8 | Argentina | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Graupe Michael | 3 |
#2 | Venkataramani Chandrasekar | 3 |
#3 | Gold Larry | 2 |
#4 | Fardis Maria | 2 |
#5 | Xu Lianhong | 2 |
#6 | Chen James M | 2 |
#7 | Jin Haolun | 2 |
#8 | Chen Xiaowu | 2 |
#9 | Guerrero Juan A | 2 |
#10 | Liu Hongtao | 2 |
Publication | Filing date | Title |
---|---|---|
CA2692768A1 | Compositions for the treatment of metabolic disorders | |
US6329145B1 | Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand |